Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Less financially secure young women who self-detect a breast change are more likely to delay seeking help, according to a recent study.
Among women with early-stage breast cancer that travels to one or more lymph nodes in the underarm, treatment with the chemotherapy medicines doxorubicin (Adriamycin) followed by docetaxel (Taxotere) may lengthen survival more than giving the two at once. This finding comes from long-term results of the Breast International Group (BIG) trial 02-98.
A study of North Carolinian women found that young African-American women were far more likely to have breast cancer treatment delay than White women in the same age range of 20 to 49.
Those enrolled in the federally-run Pre-Existing Condition Insurance Plan (PCIP) now have 2 additional months of coverage, government officials announced. Coverage will continue through March 31, 2014, to ensure people can continue their medical treatment while finding and enrolling in new health plans through state marketplaces/exchanges.
Most women feel some level of pain 1 year after breast cancer surgery, Finnish researchers found. They hope their findings, published in the Journal of the American Medical Association, help inspire new ways of preventing and treating pain to improve quality of life after surgery.
Women at high risk of developing breast cancer should now be able to get medicines to help prevent it at no cost, the U.S. Department of Health and Human Services announced.
Women 65 and older received the same treatment benefit from the combination of pertuzumab (Perjeta), trastuzumab (Herceptin) and docetaxel (Taxotere) as women 64 and younger, a sub-analysis of CLEOPATRA trial data reveals.
Each December, medical experts and researchers from around the world meet at the 5-day San Antonio Breast Cancer Symposium to share the latest findings from breast cancer clinical trials. Read on for updates from the 2013 symposium, held December 10–14.
Despite anxiety that can arise from a breast cancer diagnosis, a recent study shows that in the year that follows women may experience post-traumatic growth, or positive changes to the way they view relationships, themselves or their lives.
(Reuters) - Women with an especially deadly type of breast cancer who received a treatment regimen containing an experimental AbbVie Inc drug prior to surgery are likely to have a significantly better response than those who get a standard chemotherapy regimen, according to data from a clinical trial.